Table 3 Comparison of FT3, FT4, FT3/FT4 ratio and TSH at baseline and remission in survivors

n

19

19

30

–

age

60.9 ± 10.9

60.9 ± 10.6

55.1 ± 8.1

–

M/F (%)

9/10 (47.4/52.6)

9/10 (47.4/52.6)

13/17(43.3/56.7)

–

FT3 (pmol/L)

2.16 (1.6, 2.71)^###

3.48 (3.05, 4.07)^###

4.40 ± 0.83

 < 0.0001

FT4 (pmol/L)

9.98 ± 1.93^###

13.91 ± 2.79

14.23 ± 2.01

 < 0.0001

FT3/FT4 ratio

0.23 ± 0.08^##

0.26 ± 0.07

0.98 ± 0.74

0.13

TSH (uIU/mL)

1.15 (0.95, 1.93)

1.84 (0.90, 3.30)

1.11 (0.86,1.72)

0.113

Hs-CRP (mmol/L)

6.3 (1.7, 13.6)

2.3 (1.5, 7.5)

–

0.221

Ctnl(pg/mL)

0.08 (0.02, 0.2)

0.02 (0.006, 0.13)

–

0.403

CK (U/L)

526.4 (147.7, 1208.0)

51.9 (27.7, 96.9)

–

 < 0.0001

CK-MB (U/L)

38.7 (23.0, 52.5)

12.0 (9.3, 22.6)

–

 < 0.0001

HBDH (U/L)

524.8(338.9, 827.5)

260.9 (210.8, 334.1)

–

 < 0.0001

LDH (U/L)

886.7 (485.9, 1528.7)

309.1(261.2, 401.9)

–

 < 0.0001